Cart
sales@molnova.com
Pramiracetam
CAS No. 68497-62-1
Pramiracetam( CI-879 )
Catalog No. M15617 CAS No. 68497-62-1
A central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 35 | In Stock |
|
| 100MG | 54 | In Stock |
|
| 200MG | 86 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePramiracetam
-
NoteResearch use only, not for human use.
-
Brief DescriptionA central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.
-
DescriptionA central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.Other Indication Approved.
-
In Vitro——
-
In VivoAnimal Model:Male Long Evans hooded rats (250-300 g)Dosage:7.5, 15 mg/kg Administration:i.p.Result:Improved performance in the reference memory component of the task, but did not significantly affect the working memory component.
-
SynonymsCI-879
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number68497-62-1
-
Formula Weight269.3831
-
Molecular FormulaC14H27N3O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C
-
Chemical Name1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Lodelcizumab
Lodelcizumab (LGT 209) is a monoclonal antibody targeting the preprotein convertase Bacillus subtilis protease Kexin-9 (PCSK9) and is used to study hypercholesterolemia.
-
Neuropeptide Y (porc...
Neuropeptide Y (porcine) b
-
Methyl retinoate
Methyl retinoate (Retinoic acid, methyl ester) induces aseptic inflammation at the site of administration in in vivo experiments, which causes an increase in the number of leukocytes in the blood and a decrease in the levels of red blood cells and Hb.Methyl retinoate promotes spontaneous leukemia.Methyl retinoate can be Used in the treatment of gastric hypertrophy and ulcers due to vitamin A deficiency.
